The Canadian pyschedelics company MagicMed will be taken over by the US firm Enveric Biosciences in a move that will create greater research and development as well as commercialisation opportunities
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields
Notifications